1 / 2

Leishmaniasis Treatment

Leishmaniasis is parasitic disease caused due to an infection with Leishmania parasites and transmitted through the bite of infected female phlebotomine sand flies

poojabasmunge
Download Presentation

Leishmaniasis Treatment

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Leishmaniasis is a parasitic disease caused by the parasite Leishmania The only Food and Drug Administration (FDA)-approved medications for the Leishmaniasis treatment are intravenous liposomal amphotericin B (L-AmB) for VL and oral miltefosine for CL, ML, and VL caused by particular species. Leishmaniasis is parasitic disease caused due to an infection with Leishmania parasites and transmitted through the bite of infected female phlebotomine sand flies. There are several different forms of Leishmaniasis. The most common forms are visceral Leishmaniasis, which affects several internal organs (usually liver, spleen, and bone marrow), cutaneous Leishmaniasis, which causes skin sores, and mucocutaneous Leishmaniasis, Visceral is the most serious condition among the other two forms. According to the World Health Organization, Leishmaniasis is a curable and treatable disease, which requires an immunocompetent system because medicines will not get rid of the parasite from the body, thus the risk of relapse if immunosuppression occurs. The first of the four different Leishmaniasis treatments, called antifungal agents, is lecithin. It works by preventing inflammation and infection of capillaries. Studies have shown that this agent is effective in treating cutaneous candidiasis but may cause hypopigmentation (darkening of skin). This is a cosmetic problem that does not interfere with daily life. It responds well to systemic steroids. Coherent Market Insights

  2. Coherent Market Insights The second new Leishmaniasis treatment is miltefosine. Miltefosine is a type of monoclonal immunomodulator protein that has been shown to be efficient against a wide range of fungal infections, including Leishmaniasis. It is usually administered once a day. The third new Leishmaniasis treatment is pentavalent antimonials. These antimony compounds are similar in composition to insulin. They stimulate the pancreas to secrete more blood insulin, which help reduce the amount of glucose in the bloodstream and, over time, prevents the disease from becoming chronic. It is available under various names. Read More : https://bit.ly/3yB1WDY Coherent Market Insights

More Related